IRIS
STOLFI, CARMINE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.566
AS - Asia 3.102
EU - Europa 2.619
Continente sconosciuto - Info sul continente non disponibili 446
SA - Sud America 441
AF - Africa 54
OC - Oceania 9
Totale 29.237
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.311
SG - Singapore 1.494
IT - Italia 624
CN - Cina 570
RU - Federazione Russa 374
BR - Brasile 358
DE - Germania 310
HK - Hong Kong 276
VN - Vietnam 240
UA - Ucraina 233
IE - Irlanda 227
BD - Bangladesh 184
SE - Svezia 179
GB - Regno Unito 174
FR - Francia 149
FI - Finlandia 133
CA - Canada 107
JP - Giappone 83
KR - Corea 61
PL - Polonia 56
IN - India 47
MX - Messico 36
ID - Indonesia 27
NL - Olanda 27
AR - Argentina 26
AT - Austria 24
IQ - Iraq 21
ES - Italia 20
CO - Colombia 19
ZA - Sudafrica 19
BE - Belgio 18
CR - Costa Rica 16
JM - Giamaica 16
TR - Turchia 16
HN - Honduras 15
EC - Ecuador 14
LT - Lituania 12
PH - Filippine 11
SV - El Salvador 11
CL - Cile 9
EE - Estonia 9
EG - Egitto 9
PR - Porto Rico 9
SA - Arabia Saudita 9
AU - Australia 8
MY - Malesia 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
GP - Guadalupe 7
PY - Paraguay 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
NI - Nicaragua 6
UZ - Uzbekistan 6
GR - Grecia 5
IL - Israele 5
KZ - Kazakistan 5
MA - Marocco 5
NG - Nigeria 5
NP - Nepal 5
PK - Pakistan 5
AL - Albania 4
BB - Barbados 4
DK - Danimarca 4
GT - Guatemala 4
VE - Venezuela 4
CW - ???statistics.table.value.countryCode.CW??? 3
DM - Dominica 3
IR - Iran 3
KE - Kenya 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
AZ - Azerbaigian 2
BO - Bolivia 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HT - Haiti 2
LB - Libano 2
MT - Malta 2
PE - Perù 2
TW - Taiwan 2
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BT - Bhutan 1
BZ - Belize 1
GD - Grenada 1
GI - Gibilterra 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
Totale 28.784
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.209
Wilmington 4.612
Houston 4.455
Singapore 916
Ashburn 826
Fairfield 808
San Jose 512
Ann Arbor 464
Chandler 431
Seattle 323
Cambridge 280
Council Bluffs 269
Hong Kong 266
Beijing 225
Jacksonville 210
Dublin 204
Rome 196
Santa Clara 196
New York 168
Medford 164
Dearborn 128
The Dalles 128
Los Angeles 116
Buffalo 75
Lawrence 73
Hanoi 70
Tokyo 69
Helsinki 68
Boardman 62
Ho Chi Minh City 58
Moscow 53
Lauterbourg 52
Dallas 51
Chicago 50
Milan 47
North Bergen 47
San Diego 45
London 39
Monte Vista 38
Brooklyn 34
Kraków 34
São Paulo 33
Zhengzhou 32
Munich 30
Atlanta 28
Menlo Park 28
Mülheim 27
Phoenix 27
North Charleston 26
Denver 25
Orem 25
Montreal 23
Redondo Beach 23
Indianapolis 22
Toronto 21
Chennai 19
Boston 18
Brussels 18
Jakarta 18
Nuremberg 18
Warsaw 18
Naples 16
Seoul 16
Washington 16
Lappeenranta 15
Salt Lake City 15
Bologna 14
Johannesburg 14
Norwalk 14
Redwood City 14
Miami 13
Newark 13
Rio de Janeiro 13
San José 13
Shanghai 13
Belo Horizonte 12
Mountain View 12
Manchester 11
Palo Alto 11
San Francisco 11
Turin 11
Vienna 11
Brasília 10
Charlotte 10
Colorado Springs 10
Da Nang 10
Kingston 10
Las Vegas 10
San Salvador 10
Verona 10
Draper 9
Frankfurt am Main 9
Haiphong 9
Mexico City 9
Nanjing 9
Bari 8
Chengdu 8
Curitiba 8
Kilburn 8
Philadelphia 8
Totale 22.993
Salva come PNG Salva come JPEG
Nome #
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 608
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 587
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 565
Regulation of gut inflammation and Th17 cell response by interleukin-21 532
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 527
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 523
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 506
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 506
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 499
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 497
Colorectal cancer chemoprevention by mesalazine and its derivatives 493
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 493
The dual role of Smad7 in the control of cancer growth and metastasis 490
Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery 488
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 487
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 484
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 483
Autocrine regulation of IL-21 production in human T lymphocytes 480
Collagen matrix injection combined with flap repair for complex anal fistula 480
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 479
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 477
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 476
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 475
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 472
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 463
The dual role of inflammation in colon carcinogenesis 462
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 456
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 453
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 451
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 450
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 450
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 449
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 444
Role of TH17 cytokines in the control of colorectal cancer 435
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 433
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis 433
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 427
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 423
Molecular basis of the potential of mesalazine to prevent colorectal cancer 422
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer 412
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression 406
IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis 395
Smad7 positively regulates keratinocyte proliferation in psoriasis 394
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease 393
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 393
Interleukin-21 in cancer immunotherapy: Friend or foe? 357
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death 351
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 329
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 290
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 282
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells 245
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide 242
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 235
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 225
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 214
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells 198
{STAT}3 Interactors as Potential Therapeutic Targets for Cancer Treatment 197
Follistatin-like protein 1 sustains colon cancer cell growth and survival 172
Molecular targets of mesalazine in colorectal cancer 170
Association between celiac disease and cancer 167
Aptamer linked to DNA nanostructures diverts its traffic inside cancer cells and improves its therapeutic efficacy 166
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 165
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 164
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 156
Repositioning of anthelmintic drugs for the treatment of cancers of the digestive system 149
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases 148
RORγt-Expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells 140
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 140
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells 125
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 121
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis 117
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis 115
Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures 115
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response 114
Role of interleukin-34 in cancer 112
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut 103
A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer 96
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 96
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 93
Anthelmintic Drugs as Emerging Immune Modulators in Cancer 89
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 85
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells 83
TRAIL-Sensitizing Effects of Flavonoids in Cancer 83
The AtMYB11 gene from Arabidopsis is expressed in meristematic cells and modulates growth in planta and organogenesis in vitro 82
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders? 81
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 78
Impact of food additives on gut homeostasis 77
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis 75
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 71
Targeting Cancer Cell Energy Metabolism in Colorectal Cancer: Opportunities and Challenges from Drug Repositioning 71
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance 69
Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials 69
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut† 69
Editorial for the Special Issue “Gut Dysbiosis: Molecular Mechanisms and Therapies 2.0” 68
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier 65
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut 65
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 61
High Smad7 marks inflammation in patients with chronic pouchitis 59
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue “State-of-the-Art Molecular Oncology in Italy” 55
Special Issue “Drug Treatments for Inflammatory Bowel Diseases” 49
Totale 28.764
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.705
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022651 0 0 0 19 28 58 57 28 90 73 68 230
2022/20231.077 97 101 26 133 113 211 91 83 106 28 63 25
2023/2024423 50 17 24 13 42 109 21 80 4 4 2 57
2024/20252.343 71 538 305 179 50 204 137 88 250 257 169 95
2025/20264.527 297 161 412 355 409 165 492 539 538 456 441 262
2026/20272.002 346 256 817 583 0 0 0 0 0 0 0 0
Totale 29.237